Navigation Links
Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
Date:2/15/2011

to seamlessly incorporate its use into their existing medical practices."

In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL had been accepted for filing by the U.S. Food and Drug Administration (FDA). Pacira submitted the EXPAREL NDA in September 2010 for the initial indication of postsurgical analgesia by local administration. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA.

About EXPAREL™EXPAREL is Pacira's proprietary drug candidate consisting of bupivacaine encapsulated in DepoFoam®, both of which are currently used separately in FDA-approved products. Bupivacaine is a well-characterized anesthetic/analgesic that has an established safety profile with more than 20 years of use in the United States. Several Phase 2 and Phase 3 clinical trials have been completed for EXPAREL and demonstrate statistically significant reduction of pain in soft tissue and orthopedic surgery in different surgical models. Clinical data has also demonstrated that EXPAREL provides analgesia for up to 72 hours post-surgery compared with 7 hours or less for bupivacaine. The safety of EXPAREL was evaluated in 10 randomized, double-blind, local administration into the surgical wound clinical studies involving 823 patients; the most common adverse events following EXPAREL administration were nausea, constipation, and vomiting.

About PaciraPacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. The company's most advanced investigational product candidate, EXPAREL, a bupivacaine-based product, has completed Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encaps
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
2. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
3. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
4. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
5. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
6. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
7. ADVENTRX Pharmaceuticals Provides Update on ANX-514
8. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
9. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing
10. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
11. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that the U.S. Food and Drug Administration, ... IND, application.  Such clearance will permit Galmed to conduct ... the United States for the treatment ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire-iReach/ -- Reproductive Medicine ... New York ), a nationally and internationally-recognized leader ... requiring reproductive assistance, is pleased to announce a new ... Compassionate Care Programs to recognize the sacrifices made by ... The Compassionate Corps Program will allow qualifying veterans and ...
(Date:7/22/2014)... a privately-held medical products and technologies company, today announced ... financial officer of the company, effective July 22, 2014. ... and chief financial officer of Elan Corporation, a ... part of a senior team that helped build significant ... Perrigo, a pharmaceutical manufacturer, in December 2013. ...
Breaking Medicine Technology:Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2
... May 24, 2011 Framingham-based Boston Heart Lab announced ... Diagnostics. The company launched its new name and logo ... May 19-22 in New York City. (Logo: ... reputation every day as a high-science, high-service company that,s ...
... NEW YORK, May 24, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0284639/Triple-Analysis-Lymphoma-Melanoma-and-Peptides.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... cancer drug development strategies in both Lymphoma ...
Cached Medicine Technology:Boston Heart Lab Changes Name to Boston Heart Diagnostics 2Boston Heart Lab Changes Name to Boston Heart Diagnostics 3Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 2Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 3Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 4Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 5
(Date:7/22/2014)... 2014 The Pennsylvania judge overseeing ... in the Philadelphia Court of Common Pleas ... in cases alleging the medication caused plaintiffs to ... reports. In an Order dated July 18, 2014, ... to certify the matter for an immediate appeal ...
(Date:7/22/2014)... -- One of the largest studies ever conducted into ... 83 new sites on chromosomes that harbor inherited genes ... international team of researchers, now bring the total number ... 108. Although these schizophrenia-associated genes aren,t specific ... who will or will not develop the illness, researchers ...
(Date:7/22/2014)... 2014 CarePoint Health is pleased to announce ... President of the medical staff at Bayonne Medical Center. The ... President, as voted on by the physicians on staff. The ... in relation to the administration at Bayonne Medical Center. Dr. ... to work to make the Medical Center the best it ...
(Date:7/22/2014)... from the Edusei Foundation was greatly appreciated by the staff ... engineering, such assistance tends to etch good memories of family ... a sense of family to them, which the Edusei Foundation ... donated various amounts of; milk, soap, frytol, sugar, malt milk, ... Ghana established the Kumasi Children’s Home in 1965 to provide ...
(Date:7/22/2014)... July 22, 2014 Hospitals ... survey was conducted by Hospitals & Health ... Association, AT&T, CareTech Solutions, The College of ... Most Wired list recognizes hospitals for successful ... evaluates hospitals in four focus areas: business ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4
... fevers (FHFs) such as those caused by the Ebola ... have the support and trust of local communities, according ... of the Journal of Infectious Diseases as part of ... exist of the experiences of outbreak control teams, and ...
... growing demand for reconciling medications across the healthcare continuum ... ... of CPOE, SAN BRUNO, Calif., Oct. 29 First ... Med Knowledge Base(TM), a computerized physician order entry,(CPOE)-ready drug database ...
... Company Expands Support to 75 Percent of Military ... CACI International,Inc (NYSE: CAI ) announced today ... task order contract to support the Military Health ... the award, CACI will,supply information assurance solutions to ...
... Group ... Chicago, DALLAS, Oct. 29 Affiliated Computer Services,Inc. ... meet the changing healthcare needs of retirees, including,millions of ... Informed Health Navigator is an innovative product that analyzes,retirees, ...
... detection and treatment recommendations, , , MONDAY, Oct. 29 ... it easier for pediatricians to spot and begin ... the American Academy of Pediatrics has released two ... these conditions. , "Pediatricians are the front line" ...
... Management Diary Provides Easy Way to Record, Track and Share Health ... ... Oct. 29 ReliefInsite,( http://www.reliefinsite.com ) today unveiled a new release ... way,for companies and developers to integrate with the Facebook website. With,more ...
Cached Medicine News:Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 2Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 3Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 4Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 3Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 4Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 2Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 3Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 4Health News:ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years 2Health News:Pediatricians' Group Issues New Autism Guidelines 2Health News:Pediatricians' Group Issues New Autism Guidelines 3Health News:ReliefInsite Launches First Patient Health Record on Facebook(R) Platform 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: